Found: 26
Select item for more details and to access through your institution.
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1454, doi. 10.1007/s10637-020-00920-7
- By:
- Publication type:
- Article
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05005-2
- By:
- Publication type:
- Article
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3745, doi. 10.3390/ijms23073745
- By:
- Publication type:
- Article
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 50, doi. 10.1093/nop/npab056
- By:
- Publication type:
- Article
Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 479, n. 6, p. 1119, doi. 10.1007/s00428-021-03170-x
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
Molecular Imaging in Cancer Drug Development.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
- By:
- Publication type:
- Article
Theranostics Using Antibodies and Antibody-Related Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
- By:
- Publication type:
- Article
A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1844, doi. 10.1002/onco.13860
- By:
- Publication type:
- Article
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8395, doi. 10.1002/cam4.4342
- By:
- Publication type:
- Article
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4369, doi. 10.1007/s00259-021-05407-y
- By:
- Publication type:
- Article
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1498, doi. 10.1007/s00259-020-05068-3
- By:
- Publication type:
- Article
Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative <sup>18</sup>F-FDG PET/CT analysis.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0453-x
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1511, doi. 10.3390/cancers14061511
- By:
- Publication type:
- Article
Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4992, doi. 10.3390/cancers13194992
- By:
- Publication type:
- Article
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230901
- By:
- Publication type:
- Article
Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 257, doi. 10.3390/jpm11040257
- By:
- Publication type:
- Article
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations.
- Published in:
- Molecular Imaging & Biology, 2023, v. 25, n. 2, p. 435, doi. 10.1007/s11307-022-01775-5
- By:
- Publication type:
- Article
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article